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The objective of this paper was to investigate the incidence of extra-intestinal infections caused by Clostridium
difficile. During a 10-year period, the microbiology laboratory of our institution isolated 2034 isolates of
C. difficile. Of the 2034 isolates, 21 (1.08%) were obtained from extra-intestinal sources. This represents
an incidence of extra-intestinal isolation of four cases per 100 000 admissions. We were able to review the
records of 17 patients for our study. The isolates in 12 patients were obtained from structures or fluids
anatomically close to the colon and included the following infections: peritonitis in five cases (three primary and
two secondary), intra-abdominal abscesses in three patients and abdominal wound infections in four cases.
The infections in the other five patients were not in the anatomic vicinity of the colon. They included
one case with a brain abscess, two episodes of bacteremia and two cases of foot infections (one chronic
osteomyelitis). In all but one case, C. difficile isolation was obtained as part of a polymicrobial flora. The isolates
were frequently non-toxigenic and the extra-intestinal infections occurred without concomitant diarrhea
or prior anti-microbial therapy. Out of the 17 patients, eight died and nine survived. Death could not be directly
attributed to C. difficile in any of the cases. The isolation of C. difficile outside the intestinal tract is very
uncommon. Its clinical significance should be interpreted with caution.
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INTRODUCTION
Clostridium difficile is an anaerobic Gram-positive rod, well
known either as a coloniser of the gastrointestinal tract or as
an agent responsible for pseudomembranous colitis and many
cases of antibiotic-associated diarrhea. In contrast, reports of the
isolation of C. difficile from sites other than stools or intestinal
biopsies have been anecdotal. Thirty-three cases of bacteremia
and other extra-intestinal infections attributable to C. difficile
have been reported in the past, as recently summarized by Jacobs
et al. [1, 2]. Nevertheless, not all isolates obtained from extra-
intestinal sources are easy to interpret and on some occasions the
isolates may only represent contamination of extra-intestinal
structures with fecal flora.
In order to establish a complete spectrum of infection as well
as the clinical significance of C. difficile, we report all extra-
intestinal C. difficile isolated in our institution during the last
decade.
MATERIALS AND METHODS
Our institution is a large tertiary teaching hospital serving
approximately 650 000 inhabitants in a large city, with an
average of 50 000 admissions per year. The hospital is also a
referral center with medical and surgical specialties, including
heart, liver and kidney transplantation units, and includes a very
active human immunodeficiency virus (HIV) unit.
We analysed all extra-intestinal isolates of Clostridium difficile
taken between January 1990 and December 2000 retrospec-
tively. The strains were identified according to standard pro-
cedures including isolation in cycloserine cefoxitine fructose
agar (CCFA) medium and toxin detection in cell culture
(MRC-5) [3–5]. Susceptibility tests for metronidazole, vanco-
mycin and teicoplanin were performed by broth microdilution
following NCCLS criteria and E test (AB Biodisk, Solna,
Sweden). The available clinical and microbiological records
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of the patients with an extra-intestinal isolation of C. difficile
were reviewed.
RESULTS
During the study period, the microbiology laboratory of our
institution isolated 2034 isolates of Clostridium difficile. Of these,
2013 were either from diarrheic fecal samples or from colonic
material and only 21 (1.08%) were from extra-intestinal sources.
This represents an incidence of extra-intestinal isolation of four
cases per 100 000 admissions.
The 21 extra-intestinal C. difficile isolates were recovered
from 21 patients and we were able to obtain 17 records for our
study. Epidemiological and clinical data from the 17 patients are
shown in Table 1
The age of the patients ranged from 2 to 90 years (mean
52 4 years). Males outnumbered females (1.4:1). The most
common underlying conditions were liver cirrhosis (four cases),
endocrine disease (four cases), neoplasms (two cases) and
chronic obstructive pulmonary disease (two cases). In five
patients, gastrointestinal or biliary surgery had been performed
previously and in three of these previous intestinal damage (e.g.
ischemic colitis, thrombosis) with potential fecal spillage had
occurred.
According to clinical presentation, five patients had perito-
nitis (three primary and two secondary), but infections were
polymicrobial in all but one case. We also found three cases of
intra-abdominal abscesses, and four cases of abdominal wound
infection (two abdominal wall abscesses, two abdominal surgical
wound infections). In all the previously mentioned patients, the
isolates of C. difficile were obtained from structures or fluids
anatomically close to the colon and the majority had poly-
microbial isolates.
The infections of five patients were not in the anatomic
vicinity of the colon. They included one case with a brain
abscess after suppurative otitis media (C. difficile as well as
Streptococcus milleri and Bacteroides intermedius were isolated from
the surgically removed capsule and purulent material); one
bacteremia, probably secondary to ischemic colitis; one case
of pyelonephritis with bacteremia; one chronic case of foot
osteomyelitis and one case of infected ischemic foot tissue. In all
these cases, C. difficile was isolated as part of a polymicrobial
flora.
All but three of the cases were hospital-acquired infections.
Five patients did not have previous anti-microbial therapy. The
presence of C. difficile in stool samples was investigated in two
patients but only one had diarrhea with positive toxin assay
and culture. Cytotoxicity assay from extra-intestinal isolates was
Table1 Clinical and epidemiological data (n¼17 cases) of extra-intestinal Clostridium difficile infection
Patient Age/Sex Underlying disease Acquisition Related disease Samples Treatment Surgery Evolution
1 21/F No Community Brain abscess Abscess CAXþMTR Yes Survived
2 44/M No Community Abdominal abscess Abscess CDAþGM Yes Survived
3 22/M No Nosocomial Osteomyelitis, SWI FWE CIPþMTR No Survived




BC IMP No Died
5 42/M Cirrhosis Nosocomial Peritonitis PF IMP No Died
6 2/M No Community Appendicitis PF NR No Survived
7 54/M Cirrhosis Nosocomial Peritonitis PF CAX No Died
8 87/M COPD Nosocomial Abdominal abscess Abscess FNA AMC Yes Survived
9 70/M Cirrhosis, COPD Nosocomial Peritonitis PF IMP Yes Died
10 75/M Renal cancer
arteriopathy
Nosocomial Abdominal abscess Abscess FNA IMPþVA No Died
11 65/M Obesity Nosocomial Bacteremic peritonitis BC CIPþCAX No Died
12 53/M Hypothyroidism Nosocomial Appendicitis, SWI Wall abscess IMP Yes Survived


















16 50/F Diabetes, cirrhosis Nosocomial Peritonitis PF CAXþVA Yes Died
17 90/F Polyarthirits Nosocomial Duodenal stenosis,
SWI
Wall abscess No No Died
F, female; M, male; COPD, chronic obstructive pulmonary disease; SWI, surgical wound infection; AMC, amoxicillin-clavulanate; AMP, ampicillin; AZ, aztreo-
nam; CAX, ceftriaxone; CDA, clindamycin; GM, gentamycin; CIP, ciprofloxacin; IMP, imipenem; MTR, metronidazole; OX, dicloxacillin; VA, vancomycin; BC,
blood cultures; FNA, fine-needle aspiration; PF, peritoneal fluid; SB, surgical biopsy; FWE, fistula wound exudate; NR, not reported.
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positive in five cases. The microbiological data are summarized
in Table 2. All but one of the 17 cases investigated had a
polymicrobial infection involving aerobic and anaerobic bac-
teria as well as Candida. Susceptibility tests using broth micro-
dilution and E test were performed on eight isolates from eight
different cases. All the strains were susceptible in vitro to
metronidazole, vancomycin and teicoplanin, and were resistant
to clindamycin, imipenem and cefoxitin by both methods.
The details of treatment and outcome are outlined in Table 1.
Of the 17 patients, eight died and nine survived. Death could
not be directly attributed to C. difficile in any of the cases. The
majority of those who died were patients with severe underlying
diseases with complications that required surgical debridement
or resection that was not always feasible. The nine patients who
survived had a less severe underlying disease and eight were
treated surgically.
DISCUSSION
Clostridium difficile is considered to be the most common cause
of nosocomially acquired diarrhea, with variable incidences
between institutions. The overall incidence of C. difficile-asso-
ciated diarrhea in our institution in 1994 was 2.4 episodes per
1000 admissions [6]. The incidence has increased to 21 episodes
per 1000 admissions in the last 5 years, especially in the HIV-
positive population where it reached 28 episodes per 1000
admissions (data not published). However, the isolation of C.
difficile from extra-intestinal sites is a rare event (four cases per
100 000 admissions in our center). Until recently, only those
cases with clear clinical significance were published, generally as
short case reports. Recently, Jacobs et al. [1] reported on two
new cases and reviewed the literature on extra-colonic infec-
tions in which C. difficile was involved. They include cases
without focal isolation of C. difficile (such as reactive arthritis,
sepsis and encephalitis) [1, 7, 8], and the majority of cases are
collected and summarized from individual case reports.
Our study tries to put into perspective the whole spectrum of
C. difficile isolates obtained in a single institution from extra-
intestinal sources. There are several remarkable differences
between extra-intestinal C. difficile infection and intestinal
infections. Extra-intestinal isolates are not always associated
with toxin production (six out of the 14 available for study
in our cases were caused by non-toxigenic strains). Another
important aspect is the relationship with prior antibiotic expo-
sure. This is almost a sine qua non of C. difficile-associated
diarrhea but in our experience a history of anti-microbial
therapy in the 6 weeks preceding the event is lacking in a high
proportion of extra-intestinal C. difficile infections. Another
Table 2 Clinical isolates from samples (n¼18) of17 extra-intestinal Clostridium difficile infections
Patient Related disease Samples Clostridium difficile plus
1 Brain abscess Abscess SE Streptococcus milleri, Bacteroides intermedius
2 Abdominal abscess Abscess SE Escherichia coli, S. group C, B. fragilis
3 Osteomyelitis, SWI 2 FWE Enterococcus faecium, Enterobacter aerogenes, Clostridium
butyricum
4 Bacteremic pyelonephritis BC Enterococcus faecium, Bacteroids fragilis
5 Peritonitis PF ^
6 Appendicitis PF E. coli, Bacteroides spp.
7 Peritonitis PF Pseudomonas aeruginosa, E. faecalis, B. fragilis,
B. thetaiotaomicron
8 Abdominal abscess Abscess FNA E. coli, E. faecalis, Staphylococcus aureus,Candida tropicalis,
B. fragilis, Clostridium perfringens
9 Peritonitis PF E. coli, S. aureus, S. plymuthica, E. faecium,
B. distasonis, C. perfringens
10 Abdominal abscess Abscess FNA E. coli, S. aureus, Clrobacter freundii
11 Bacteremic peritonitis BC E. faecium, B. ovatus
12 Appendicitis, SWI Wall abscess Klebsiella oxytoca, B. thetaiotaomicron
13 Ileostomy wound
infection and fistulae
FWE E. coli, Candida albicans
14 Necrotic ischemic
distal lesion
SB S. aureus, S. viridans, Acinetobacter spp., Prevotella
15 Ileostomy wound
infection and fistulae
FWE E. coli, Klebsiella pneumoniae, P. mirabilis, E. faecalis,
C. perfringens, B. fragilis
16 Peritonitis PF E. coli, E. faecium
17 Duodenal stenosis, SWI Wall abscess S. viridans, S coagulase negative
BC, blood cultures; FNA, fine needle aspirate; FWE, fistula wound exudate; PF, peritoneal fluid; SB, surgical biopsy; SE, surgically excised; SWI surgical wound
infection; UC, urine cultures.
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potential distinguishing feature of extra-intestinal C. difficile
infections is the involvement of children. This is very uncom-
mon in C. difficile-associated diarrhea, but pediatric patients
were involved in the extra-intestinal C. difficile infections [1, 9].
One of our patients was a 2-year-old child with appendicitis and
an intra-abdominal abscess from which C. difficile was isolated.
As our case series clearly shows, the interpretation of the
isolation of C. difficile from extra-intestinal sources is often
difficult. In the vast majority of cases the isolate is either part
of a polymicrobial flora or is isolated from intra-abdominal
collections or tissues in the vicinity of the colon in patients with
evident or probable recent fecal spillage. In our series, we
detected five cases of peritonitis and three of intra-abdominal
abscess. A previous history of complicated surgery and/or
colonic lesions was recorded in nine cases. The most believable
episodes of extra-intestinal infection due to C. difficile are those
with pure culture isolates from visceral abscesses (splenic,
pancreatic, liver) [2, 10–14] or with positive blood cultures
[1, 15–20]. In our series, two cases of C. difficile bacteremia were
recorded. One was associated with ischemic colitis after cardiac
surgery. In the second case, the bacteremia was the consequence
of the intestinal invasion of an advanced bladder cancer.
Although the reports refer to a low mortality rate, our two
cases died. We did not find any case of severe sepsis secondary to
a fulminant pseudomembranous colitis as described elsewhere
[21]. Fewer than a dozen cases of clearly established skin and soft
tissue infection and osteomyelitis have been reported [22–29].
Again, the spreading of C. difficile through contaminated
wounds after trauma or surgical injury may be potentially
misleading. Finally, other reports include cases of C. difficile
empyema or pleural effusion [30, 31].
The role of C. difficile in the pathogenesis of extra-intestinal
diseases or in their associated mortality is very difficult to assess.
Among our own patients, no death could be directly attributed
to C. difficile, but mortality was high due to the severe under-
lying diseases and critical conditions of these patients.
In conclusion, the isolation of C. difficile from a wide range of
specimens outside the intestinal tract is very uncommon. Its
presence should be interpreted with caution as many variables
may be misleading. At the present time, there is no indication
of the need for specifically directed therapy in many of the
cases.
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